Dosing & Uses
AdultPediatric
Meningococcal Vaccination
Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 years
Meningococcal Vaccination
Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 years
Next:
Pharmacology
Mechanism of Action
Pentavalent vaccine targeting meningococcal serogroups A, B, C, Y and W
Conveys active immunity via stimulation of production of endogenously produced antibodies
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
